Dyskinesia describes a group of involuntary movement disorders caused by abnormal functioning of the brain. The condition interferes with body movement, including walking, eating, speaking, and writing. It can also affect facial expressions and other activities involving facial, shoulder, or limb movements. The most common type of dyskinesia is tardive dyskinesia. This disorder is usually caused by long-term treatment with certain antipsychotic medications used to treat schizophrenia and other psychotic disorders. Tardive dyskinesia typically manifests with involuntary, repetitive muscle movements, such as rapid blinking, lip smacking, grimacing, tongue thrusting, and hand movements. Another type of dyskinesia is Drug-Induced Dyskinesia, which is caused by the use of certain drugs, including levodopa, used to treat Parkinson’s Disease. Drug-induced dyskinesia can range from mild to severe and may include involuntary arm and leg movements, as well as facial tics and other muscle-related symptoms. Though there is no single treatment that can cure dyskinesia, try to manage it. One of the primary treatment methods is adjusting the dosage or discontinuing the use of the triggering drug. In some cases, medications, such as trihexyphenidyl, may be prescribed to reduce or stop the abnormal movements. Additionally, many medications are available to treat the specific symptoms of dyskinesia, including serotonin reuptake inhibitors (SSRIs) to reduce muscle spasms, antidepressants to manage depression, and anticonvulsants to treat seizures. Physical therapy is also often recommended to help with the muscle symptoms. Exercises focused on stretching and strengthening the muscles can help improve mobility and relieve symptoms. Biofeedback, an approach in which specific muscles are focused on to reduce involuntary movement, is also a possible treatment. In conclusion, dyskinesia is an umbrella term for a group of movement disorders that occur due to abnormal functioning of the brain. While there is no cure for dyskinesia, symptoms can be managed with medication, physical therapy, and other treatments.
Title : Perception and individuality
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : ACE-dependent Alzheimer’s Disease (AD)
Sergei M Danilov, University of Illinois, United States
Title : Essential roles, mechanisms and consequences of vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Neuroimaging by evaluation nerverenovate and neuroplasticity of acupuncture in children with cerebral palsy
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : The foundation and architecture of Personalized & Precision Medicine (PPM) in clinical neurology: Towards curative and neurodegenerative disease-modifying treatment for multiple sclerosis
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Who cares …… for the carers
Jaqueline Tuppen, COGS Club, United Kingdom